Dopamine Signaling Pathway in Health and Disease—2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 64
Special Issue Editors
Interests: synaptic plasticity; synaptic transmission; signaling pathways; regulation of gene expression
Special Issues, Collections and Topics in MDPI journals
Interests: Neuromodulation; synaptic plasticity; learning and memory; neurodegeneration
Special Issues, Collections and Topics in MDPI journals
Interests: neuronal plasticity and homeostasis; autophagy; protein synthesis; intellectual disability
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Dopamine plays a pivotal role as a neurotransmitter, regulating numerous essential physiological functions within the central nervous system. These functions encompass motor behavior, affective and emotional states, reward and reinforcement behaviors, as well as various higher cognitive functions. The four primary dopaminergic pathways are the nigrostriatal, mesocortical, mesolimbic, and tuberoinfundibular pathways. Dysfunction in the dopaminergic transmission is recognized as a core alteration in several neurological and psychiatric disorders, including Parkinson’s disease, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder (ADHD), and addiction.
This Special Issue, titled "Dopamine Signaling Pathway in Health and Disease—2nd Edition", will feature a curated collection of original research papers and reviews. These contributions will explore the cellular and molecular mechanisms that underlie dopaminergic neuromodulation under physiological conditions, as well as in preclinical cellular and animal models of dopaminergic neurodegeneration. Additionally, the issue will examine innovative pharmacological approaches for addressing dopamine-related disorders.
Prof. Dr. Floriana Volpicelli
Prof. Dr. Maria Concetta Miniaci
Dr. Luisa Speranza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- differentiation
- disease modeling
- dopamine and drugs
- gene expression
- human stem cells
- neuronal development
- reprogramming
- signaling pathways
- neurodegeneration
- neuromodulation
